Overview: Zoladex 3.6 Injection contains Goserelin Acetate (3.6 mg), a prescription hormonal therapy used to treat prostate cancer in men by lowering testosterone levels and various hormone-sensitive conditions including breast cancer in premenopausal women, endometriosis and uterine fibroids by reducing estrogen levels. Key Benefits: – Helps slow the progression of hormone-sensitive prostate cancer – Useful in hormone therapy for select breast cancers – Aids in managing endometriosis and uterine fibroid symptoms – Administered as a monthly subcutaneous implant Composition: Goserelin Acetate (3.6 mg) How It Works: Goserelin Acetate is a GnRH (gonadotropin-releasing hormone) agonist that lowers production of sex hormones (testosterone and estrogen) by long-term pituitary receptor down-regulation, reducing hormone-driven tumor growth or gynecological symptom progression. Usage Instructions: – Administer only by a qualified healthcare professional via subcutaneous implant usually every 28 days – Follow the prescribed schedule strictly for effective hormone suppression – Not for self-administration Side Effects: – Hot flashes, sweating, headache – Reduced libido or sexual dysfunction – Mood changes, injection site discomfort – Bone mineral density reduction with long-term use Precautions: – Not to be used during pregnancy or breastfeeding — discuss with your healthcare provider – Regular monitoring of hormone levels, bone health and symptoms is advised – Inform your doctor of all current medications before starting treatment Storage Instructions: – Store below 25°C in a cool, dry place away from moisture and light Manufacturer: AstraZeneca / Generic Pharmaceuticals Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.